Titan Medical (TMDIF) Competitors

AVITA Medical (NASDAQ:RCEL) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Does the MarketBeat Community prefer RCEL or TMDIF?

AVITA Medical received 74 more outperform votes than Titan Medical when rated by MarketBeat users.

Company	Underperform	Outperform
AVITA Medical	Outperform Votes 74 67.89%	Underperform Votes 35 32.11%
Titan Medical	N/A	N/A

Which has more risk and volatility, RCEL or TMDIF?

AVITA Medical has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.

Is RCEL or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to AVITA Medical's net margin of -95.47%. Titan Medical's return on equity of -82.31% beat AVITA Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AVITA Medical	-95.47%	-194.69%	-60.67%
Titan Medical	N/A	-82.31%	-51.47%

Which has better earnings and valuation, RCEL or TMDIF?

Titan Medical has lower revenue, but higher earnings than AVITA Medical. AVITA Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AVITA Medical	$50.14M	6.25	-$35.38M	-$2.23	-5.36
Titan Medical	$17.63M	4.53	$6.95M	$0.05	14.00

Do institutionals & insiders have more ownership in RCEL or TMDIF?

27.7% of AVITA Medical shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 1.8% of AVITA Medical shares are held by insiders. Comparatively, 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the media favor RCEL or TMDIF?

In the previous week, AVITA Medical had 3 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for AVITA Medical and 1 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.75 beat AVITA Medical's score of 0.07 indicating that Titan Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AVITA Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Titan Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend RCEL or TMDIF?

AVITA Medical currently has a consensus price target of $16.50, indicating a potential upside of 38.08%. Given AVITA Medical's stronger consensus rating and higher possible upside, analysts plainly believe AVITA Medical is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AVITA Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

AVITA Medical beats Titan Medical on 10 of the 17 factors compared between the two stocks.